Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector

dc.contributor.authorLiu, Jenny X.
dc.contributor.authorSchatzkin, Eric
dc.contributor.authorOmoluabi, Elizabeth
dc.contributor.authorFajemisin, Morenike
dc.contributor.authorOnuoha, Chidinma Lucy
dc.contributor.authorErinfolami, Temitope Peter
dc.contributor.authorAyodeji, Kazeem
dc.contributor.authorOgunmola, Saliu
dc.contributor.authorShen, Jennifer
dc.contributor.authorDiamond-Smith, Nadia G.
dc.contributor.authorSieverding, Maia
dc.contributor.departmentHealth Promotion and Community Health (HPCH)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:36:04Z
dc.date.available2025-01-24T11:36:04Z
dc.date.issued2018
dc.description.abstractObjectives: The subcutaneous depot medroxyprogesterone acetate (DMPA-SC) injectable contraceptive was introduced in South West Nigeria in 2015 through private sector channels. The introduction included community-based distribution and was supported by a social marketing approach. From program monitoring and evaluation, aimed at understanding performance, market reach and other process measures, we identify lessons learned to inform future scale-up efforts. Methods: We synthesized the findings from a core set of key performance indicators collected through different methods: (1) implementer performance indicators, (2) phone survey of DMPA-SC users (n=541) with a follow-up after 3 months (n=342) and (3) in-depth interviews with 57 providers and 42 users of DMPA-SC. Results: Distribution of DMPA-SC to private providers was concentrated in states with large urban populations. A shift toward focusing on high-volume family planning facilities coincided with a rapid increase in distribution in late 2016. Users reached in the phone survey were generally older and married with children; few were under age 25. Users and providers reported favorable opinions of DMPA-SC. Many users reported choosing DMPA-SC due to recommendations from providers and friends, and the hope of experiencing reduced side effects compared to other methods. While users reported positive experiences interacting with community-based distributors, the delivery model encountered a number of challenges — high turnover, low motivation, lack of an appropriate compensation package and logistical costs — and was ultimately disbanded. Conclusions: In the DMPA-SC introductory program in Nigeria, distribution was amplified when focused on high-volume contraceptive providers. Although community-based distribution can be one effective service delivery model for reaching underserved populations, more consideration for balancing cost recovery and public health goals through private sector approaches are needed in the context of South West Nigeria. Additional communications and outreach efforts are needed to reach younger, unmarried users with contraceptive services. © 2018 The Author(s)
dc.identifier.doihttps://doi.org/10.1016/j.contraception.2018.07.005
dc.identifier.eid2-s2.0-85051516653
dc.identifier.pmid30071196
dc.identifier.urihttp://hdl.handle.net/10938/28510
dc.language.isoen
dc.publisherElsevier USA
dc.relation.ispartofContraception
dc.sourceScopus
dc.subjectCommunity-based distribution
dc.subjectInjectable contraceptive
dc.subjectNigeria
dc.subjectPrivate sector
dc.subjectSocial marketing
dc.subjectSubcutaneous depot medroxyprogesterone acetate
dc.subjectAdult
dc.subjectContraception behavior
dc.subjectContraceptive agents, female
dc.subjectDelivery of health care
dc.subjectFemale
dc.subjectHumans
dc.subjectInjections, subcutaneous
dc.subjectMedroxyprogesterone acetate
dc.subjectYoung adult
dc.subjectNorethisterone enantate
dc.subjectContraceptive agent
dc.subjectArticle
dc.subjectContraception
dc.subjectControlled study
dc.subjectDrug cost
dc.subjectFamily planning
dc.subjectFollow up
dc.subjectHuman
dc.subjectMajor clinical study
dc.subjectMarried person
dc.subjectMotivation
dc.subjectShelf life
dc.subjectSide effect
dc.subjectUrban population
dc.subjectContraceptive behavior
dc.subjectHealth care delivery
dc.subjectSubcutaneous drug administration
dc.titleIntroducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-7957.pdf
Size:
633.71 KB
Format:
Adobe Portable Document Format